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A B S T R A C T
Ganglioneuromas are rare, benign, slow-growing tumors originating from sympathetic ganglion cells. The most
common locations are the posterior mediastinum and retroperitoneum. Pelvic ganglioneuroma is very rare. The case of a
12-year-old girl with presacral ganglioneuroma is reported. The importance of considering a confident preoperative di-
agnosis by fine-needle aspiration biopsy is stressed.
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Introduction
Ganglioneuroma is a rare neoplasm composed en-
tirely of mature ganglion cells and Schwannian stroma.
It arises anywhere along the sympathetic nerve chain.
The most affected anatomic site is the posterior media-
stinum, followed by retroperitoneum, adrenal gland, and
neck. The clinical behaviour of ganglioneuroma in in-
variably benign, and complete surgical resection is con-
sidered to be curative1,2.
Herein, an extremely rare case of pelvic ganglio-
neuroma in a child is reported. Very few reports on the
cytological appearance of this tumor exist3. The utility of
preoperative fine-needle aspiration in the diagnosis of
ganglioneuroma, and its routine incorporation in the
evaluation of pelvic masses in children is discussed.
Case Report
A 12-year-old girl presented with a complaint of lower
abdominal pain for a foregoing week. Her past medical
history and physical examination were unremarkable.
Abdominal ultrasound (US) showed a large, solid,
pseudo-capsulated, well circumscribed pelvic tumor with
a few calcified foci, and the patient was hospitalized for
further evaluation. The digital rectal examination dis-
closed a firm non-tender mass palpable just in front of
the sacrum. Sedimentation rate, complete blood count,
and blood chemistry tests were within normal limits, ex-
cept for decreased levels of serum iron (40 mcg/dL) and
ferritin (14.7 ng/mL). Serum tumor markers including
neuron specific enolase, CEA, CA 19-9, CA 125, alpha-fe-
toprotein, and human chorionic gonadotropin were
normal. Plasma and urine catecholamines as well as
their metabolites homovanillic acid and vanillylmandelic
acid were within the normal range. Pelvic computed to-
mography (CT) revealed a 9x8x7.5 cm solid, well defined
mass in the presacral region with discrete speckled cal-
cifications. Contrast-enhanced CT showed slight inho-
mogeneous enhancement. The uterus and rectum were
compressed without invasion, and displaced ventrally
and laterally. Magnetic resonance imaging (MRI) demon-
strated a hypointense homogeneous tumor on T1-weight-
ed images, and a hyperintense heterogeneous lesion on
T2-weighted images. There was no extension into the sa-
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Fig. 1. Large binuclear cell with prominent nucleoli and stromal
fragment. May-Gruenwald-Giemsa stain, x1000.
cral foramina. These radiological findings were sugges-
tive for the neural tumor.
US-guided fine needle aspiration was performed. The
smears contained rare large cells with one to three nuclei
and prominent nucleoli, and stromal fragments. These
cells had features of ganglion cells (Figure 1). CT-guided
biopsy was done. The histologic examination proved the
lesion as ganglioneuroma composed of both mature gan-
glion cells and spindle Schwann cells (Figure 2). A com-
plete surgical resection was performed using an anterior
approach. The diagnosis of ganglioneuroma was subse-
quently confirmed on postoperative histopathologic ex-
amination. At a 3-year follow-up, the patient is asymp-
tomatic and without evidence of disease.
Discussion and Conclusion
Neuroblastoma, ganglioneuroblastoma, and ganglio-
neuroma are tumors of the sympathetic nervous system
that originate from primordial neural crest cells. These
precursor cells may remain undifferentiated, referred to
as neuroblasts, or may mature to ganglion and Schwann
cells4. A tumor composed primarily of neuroblasts is a
neuroblastoma, a tumor composed of mature ganglion
cells and other mature tissue is referred to as ganglio-
neuroma, and a tumor with both immature and mature
cell types is a ganglioneuroblastoma. In other words,
these tumors collectively known as a group of neuro-
blastic or neurogenic tumors, define a spectrum of sym-
pathetic tissue tumors, ranging from undifferentiated
neuroblastoma to the mature ganglioneuroma. The pres-
ence of immature tissue in neuroblastoma and ganglio-
neuroblastoma indicates malignant or potentially malig-
nant behavior; ganglioneuroma is considered benign tu-
mor2,4.
Neuroblastic tumors are classified according to the
International Neuroblastoma Pathology Classification
(INPC), established in 1999 by adopting the system of
the original Shimada Classification and partly modified
in 2003 (7 categories: neuroblastoma, Schwannian stro-
ma-poor; ganglioneuroblastoma, intermixed, Schwan-
nian stroma-rich; ganglioneuroma, Schwannian stroma-
-dominant; ganglioneuroblastoma, nodular; neuroblastic
tumor, unclassifiable; neuroblastoma, not otherwise spe-
cified; ganglioneuroblastoma, not otherwise specified)5.
INPC classification has been used as one of the most
powerful front-end prognostic factors for patient stratifi-
cation and protocol assignment in this disease6.
Ganglioneuromas are rare, fully-differentiated neuro-
blastic tumors that contain mature ganglion cells, ma-
ture Schwann cells, fibrous tissue, and nerve fibers.
These tumors have no immature elements, such as ne-
uroblasts or intermediate cells, atypia, mitotic figures, or
necrosis2. Ganglioneuromas may arise de novo, or result
from the maturation of neuroblastomas and ganglioneu-
roblastomas. They can also develop from neuroblastomas
that were treated with chemotherapy2,6. The relative fre-
quency of spontaneously occurring tumors and those
arising from maturing or treated malignant counterparts
is unknown. There are very few reports of metastatic
ganglioneuromas. These metastases are believed to be
the end result of matured neuroblastoma or ganglio-
neuroblastoma metastases, and these patients have an
excellent prognosis2,7.
Ganglioneuroma usually occurs in adolescents and
young adults (40–60%), but individuals of all ages can be
affected2. The median age of occurrence is 7 years, with
different studies reporting a median age of 5.5 years, 7
years, and over 10 years7. There is a slight female pre-
dominance, ranging from 1.13:1 to 1.5:17,8. Ganglio-
neuroma can grow wherever sympathetic nervous tissue
exists. The most common locations are the posterior
mediastinum (41.5% of cases), retroperitoneum (37.5%),
adrenal gland (21%), and neck (8%). Unusual sites inclu-
de the spermatic cord, urinary bladder, intestine, abdom-
inal wall, heart, bone, skin, and gallbladder2. Ganglio-
neuromas are usually asymptomatic, and are typically
discovered on a routine radiographic study such as chest
radiograph. Sometimes they cause local mass effect, and
patients may present with cough, dyspnea, abdominal
pain, and palpation of an abdominal mass7. These tu-
mors may be hormonally active, thus manifesting with
hypertension, flushing and other symptoms as a result of
catecholamine secretion9. It was believed that hormone
production by ganglioneuroma is unusual, but there are
several reports confirming that ganglioneuromas secrete
catecholamines in as many as 37% of cases2,7. Ganglio-
neuroma averages 8 cm in diameter and may appear en-
capsulated, although a true capsule is rare4. Magnetic
resonance imaging and computed tomography scanning
are the preferred methods for imaging10. Although gan-
glioneuroma tends to be more homogeneous tumor than
neuroblastoma or ganglioneuroblastoma, it is not possi-
ble at imaging evaluation to discriminate among these
three tumors. Up to 60% of ganglioneuromas show cal-
cifications; they are typically fine and speckled but may
be coarse2,11. Treatment consists of complete surgical ex-
cision when possible. Because of the benign nature of
ganglioneuroma, adjuvant chemotherapy or radiother-
apy is not indicated1,2. Local recurrence has been re-
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Fig. 2. Ganglioneuroma. Fascicles of spindle Schwann cells
along with mature ganglion cells, some of them binucleated.
Hemalaun-eosin stain, x200.
ported, so periodic radiological follow-up is indicated af-
ter resection12.
The present case describes an extremely rare pre-
sacral ganglioneuroma. A literature search has revealed
only 18 case reports to date. The largest published series
of presacral location includes five patients13. On diagnos-
tic evaluation of the reported patient, CT and MRI sug-
gested neural tumor. Preoperative study was completed
by fine needle aspiration cytology and histopathology.
The tumor was completely resected, and postoperative
histologic examination confirmed the diagnosis of gan-
glioneuroma.
Pediatric sacral tumors usually occur in the newborn
period, with most of these tumors being sacrococcygeal
teratomas. Other benign congenital tumors of the sacral
region include lipomas, dermoids, and epidermoids14.
Ganglioneuroma, although very rare, should be consid-
ered in the differential diagnosis of nonteratomatous sa-
cral tumors in pediatric age group. Because it shares clin-
ical and radiological features with other benign and
malignant neural tumors, accurate preoperative diagno-
sis is often difficult, but critical for proper management.
This case illustrates the utility of preoperative fine-nee-
dle aspiration biopsy in the diagnosis of ganglioneuroma.
Although technical approach may be hard, this is a rapid,
simple, cost-effective, and safe diagnostic procedure. Ad-
equate sampling, experience and caution in interpreting
the specimen, as well as a close collaboration between pe-
diatric oncologist, radiologist and cytopathologists are
essential for its success.
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PELVI^NI GANGLIONEUROM
S A @ E T A K
Ganglioneuromi su rijetki, benigni, sporo rastu}i tumori porijeklom iz simpati~kih ganglijskih stanica. Naj~e{}e su
lokalizirani u stra`njem medijastinumu i retroperitoneumu. Pelvi~na lokalizacija je vrlo rijetka. U radu je prikazan
slu~aj 12-godi{nje djevoj~ice s presakralnim ganglioneuromom. Nagla{ena je va`nost pouzdane preoperativne dijagnoze
aspiracijskom biopsijom tankom iglom.
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